Shopping Cart 0
Cart Subtotal
AED 0

Global Dolutegravir Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 17910

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 26864

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 35819

Details

Scope of the Report:

The worldwide market for Dolutegravir is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2024, from xx million USD in 2019, according to a new GIR (Global Info Research) study.

This report focuses on the Dolutegravir in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

ViiV Healthcare (GSK)

Shanghai Desano Pharmaceuticals

Mylan

Aurobindo Pharma

LAURUS Labs

Adcock Ingram Limited

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

10mg Tablets

50mg Tablets

Market Segment by Applications, can be divided into

Prevent HIV Infection Following Potential Exposure

Other

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Dolutegravir product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Dolutegravir, with price, sales, revenue and global market share of Dolutegravir in 2017 and 2018.

Chapter 3, the Dolutegravir competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Dolutegravir breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Dolutegravir market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Dolutegravir sales channel, distributors, customers, research findings and conclusion, appendix and data source.

READ MORE

Table Of Content

Scope

Table of Contents

1 Market Overview

1.1 Dolutegravir Introduction

1.2 Market Analysis by Type

1.2.1 10mg Tablets

1.2.2 50mg Tablets

1.3 Market Analysis by Applications

1.3.1 Prevent HIV Infection Following Potential Exposure

1.3.2 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 ViiV Healthcare (GSK)

2.1.1 Business Overview

2.1.2 Dolutegravir Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 ViiV Healthcare (GSK) Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 Shanghai Desano Pharmaceuticals

2.2.1 Business Overview

2.2.2 Dolutegravir Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Shanghai Desano Pharmaceuticals Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 Mylan

2.3.1 Business Overview

2.3.2 Dolutegravir Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Mylan Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Aurobindo Pharma

2.4.1 Business Overview

2.4.2 Dolutegravir Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Aurobindo Pharma Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 LAURUS Labs

2.5.1 Business Overview

2.5.2 Dolutegravir Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 LAURUS Labs Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 Adcock Ingram Limited

2.6.1 Business Overview

2.6.2 Dolutegravir Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Adcock Ingram Limited Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Dolutegravir Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Dolutegravir Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Dolutegravir Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Dolutegravir Manufacturer Market Share in 2018

3.3.2 Top 6 Dolutegravir Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Dolutegravir Market Analysis by Regions

4.1 Global Dolutegravir Sales, Revenue and Market Share by Regions

4.1.1 Global Dolutegravir Sales and Market Share by Regions (2014-2019)

4.1.2 Global Dolutegravir Revenue and Market Share by Regions (2014-2019)

4.2 North America Dolutegravir Sales and Growth Rate (2014-2019)

4.3 Europe Dolutegravir Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Dolutegravir Sales and Growth Rate (2014-2019)

4.5 South America Dolutegravir Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Dolutegravir Sales and Growth Rate (2014-2019)

5 North America Dolutegravir by Country

5.1 North America Dolutegravir Sales, Revenue and Market Share by Country

5.1.1 North America Dolutegravir Sales and Market Share by Country (2014-2019)

5.1.2 North America Dolutegravir Revenue and Market Share by Country (2014-2019)

5.2 United States Dolutegravir Sales and Growth Rate (2014-2019)

5.3 Canada Dolutegravir Sales and Growth Rate (2014-2019)

5.4 Mexico Dolutegravir Sales and Growth Rate (2014-2019)

6 Europe Dolutegravir by Country

6.1 Europe Dolutegravir Sales, Revenue and Market Share by Country

6.1.1 Europe Dolutegravir Sales and Market Share by Country (2014-2019)

6.1.2 Europe Dolutegravir Revenue and Market Share by Country (2014-2019)

6.2 Germany Dolutegravir Sales and Growth Rate (2014-2019)

6.3 UK Dolutegravir Sales and Growth Rate (2014-2019)

6.4 France Dolutegravir Sales and Growth Rate (2014-2019)

6.5 Russia Dolutegravir Sales and Growth Rate (2014-2019)

6.6 Italy Dolutegravir Sales and Growth Rate (2014-2019)

7 Asia-Pacific Dolutegravir by Country

7.1 Asia-Pacific Dolutegravir Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Dolutegravir Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Dolutegravir Revenue and Market Share by Country (2014-2019)

7.2 China Dolutegravir Sales and Growth Rate (2014-2019)

7.3 Japan Dolutegravir Sales and Growth Rate (2014-2019)

7.4 Korea Dolutegravir Sales and Growth Rate (2014-2019)

7.5 India Dolutegravir Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Dolutegravir Sales and Growth Rate (2014-2019)

8 South America Dolutegravir by Country

8.1 South America Dolutegravir Sales, Revenue and Market Share by Country

8.1.1 South America Dolutegravir Sales and Market Share by Country (2014-2019)

8.1.2 South America Dolutegravir Revenue and Market Share by Country (2014-2019)

8.2 Brazil Dolutegravir Sales and Growth Rate (2014-2019)

8.3 Argentina Dolutegravir Sales and Growth Rate (2014-2019)

8.4 Colombia Dolutegravir Sales and Growth Rate (2014-2019)

9 Middle East and Africa Dolutegravir by Countries

9.1 Middle East and Africa Dolutegravir Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Dolutegravir Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Dolutegravir Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Dolutegravir Sales and Growth Rate (2014-2019)

9.3 Turkey Dolutegravir Sales and Growth Rate (2014-2019)

9.4 Egypt Dolutegravir Sales and Growth Rate (2014-2019)

9.5 Nigeria Dolutegravir Sales and Growth Rate (2014-2019)

9.6 South Africa Dolutegravir Sales and Growth Rate (2014-2019)

10 Global Dolutegravir Market Segment by Type

10.1 Global Dolutegravir Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Dolutegravir Sales and Market Share by Type (2014-2019)

10.1.2 Global Dolutegravir Revenue and Market Share by Type (2014-2019)

10.2 10mg Tablets Sales Growth and Price

10.2.1 Global 10mg Tablets Sales Growth (2014-2019)

10.2.2 Global 10mg Tablets Price (2014-2019)

10.3 50mg Tablets Sales Growth and Price

10.3.1 Global 50mg Tablets Sales Growth (2014-2019)

10.3.2 Global 50mg Tablets Price (2014-2019)

11 Global Dolutegravir Market Segment by Application

11.1 Global Dolutegravir Sales Market Share by Application (2014-2019)

11.2 Prevent HIV Infection Following Potential Exposure Sales Growth (2014-2019)

11.3 Other Sales Growth (2014-2019)

12 Dolutegravir Market Forecast (2019-2024)

12.1 Global Dolutegravir Sales, Revenue and Growth Rate (2019-2024)

12.2 Dolutegravir Market Forecast by Regions (2019-2024)

12.2.1 North America Dolutegravir Market Forecast (2019-2024)

12.2.2 Europe Dolutegravir Market Forecast (2019-2024)

12.2.3 Asia-Pacific Dolutegravir Market Forecast (2019-2024)

12.2.4 South America Dolutegravir Market Forecast (2019-2024)

12.2.5 Middle East and Africa Dolutegravir Market Forecast (2019-2024)

12.3 Dolutegravir Market Forecast by Type (2019-2024)

12.3.1 Global Dolutegravir Sales Forecast by Type (2019-2024)

12.3.2 Global Dolutegravir Market Share Forecast by Type (2019-2024)

12.4 Dolutegravir Market Forecast by Application (2019-2024)

12.4.1 Global Dolutegravir Sales Forecast by Application (2019-2024)

12.4.2 Global Dolutegravir Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Dolutegravir Picture

Table Product Specifications of Dolutegravir

Figure Global Sales Market Share of Dolutegravir by Types in 2018

Table Dolutegravir Types for Major Manufacturers

Figure 10mg Tablets Picture

Figure 50mg Tablets Picture

Figure Dolutegravir Sales Market Share by Applications in 2018

Figure Prevent HIV Infection Following Potential Exposure Picture

Figure Other Picture

Figure United States Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure Canada Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure Mexico Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure Germany Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure France Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure UK Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure Russia Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure Italy Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure China Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure Japan Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure Korea Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure India Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure Southeast Asia Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure Brazil Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure Egypt Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure Saudi Arabia Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure South Africa Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure Nigeria Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Table ViiV Healthcare (GSK) Basic Information, Manufacturing Base and Competitors

Table ViiV Healthcare (GSK) Dolutegravir Type and Applications

Table ViiV Healthcare (GSK) Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Shanghai Desano Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Shanghai Desano Pharmaceuticals Dolutegravir Type and Applications

Table Shanghai Desano Pharmaceuticals Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Mylan Basic Information, Manufacturing Base and Competitors

Table Mylan Dolutegravir Type and Applications

Table Mylan Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Aurobindo Pharma Basic Information, Manufacturing Base and Competitors

Table Aurobindo Pharma Dolutegravir Type and Applications

Table Aurobindo Pharma Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table LAURUS Labs Basic Information, Manufacturing Base and Competitors

Table LAURUS Labs Dolutegravir Type and Applications

Table LAURUS Labs Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Adcock Ingram Limited Basic Information, Manufacturing Base and Competitors

Table Adcock Ingram Limited Dolutegravir Type and Applications

Table Adcock Ingram Limited Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Global Dolutegravir Sales by Manufacturer (2017-2018)

Figure Global Dolutegravir Sales Market Share by Manufacturer in 2017

Figure Global Dolutegravir Sales Market Share by Manufacturer in 2018

Table Global Dolutegravir Revenue by Manufacturer (2017-2018)

Figure Global Dolutegravir Revenue Market Share by Manufacturer in 2017

Figure Global Dolutegravir Revenue Market Share by Manufacturer in 2018

Figure Top 3 Dolutegravir Manufacturer (Revenue) Market Share in 2018

Figure Top 6 Dolutegravir Manufacturer (Revenue) Market Share in 2018

Figure Global Dolutegravir Sales and Growth Rate (2014-2019)

Figure Global Dolutegravir Revenue and Growth Rate (2014-2019)

Table Global Dolutegravir Sales by Regions (2014-2019)

Table Global Dolutegravir Sales Market Share by Regions (2014-2019)

Table Global Dolutegravir Revenue by Regions (2014-2019)

Figure Global Dolutegravir Revenue Market Share by Regions (2014-2019)

Figure Global Dolutegravir Revenue Market Share by Regions in 2018

Figure North America Dolutegravir Sales and Growth Rate (2014-2019)

Figure Europe Dolutegravir Sales and Growth Rate (2014-2019)

Figure Asia-Pacific Dolutegravir Sales and Growth Rate (2014-2019)

Figure South America Dolutegravir Sales and Growth Rate (2014-2019)

Figure Middle East and Africa Dolutegravir Sales and Growth Rate (2014-2019)

Figure North America Dolutegravir Revenue and Growth Rate (2014-2019)

Table North America Dolutegravir Sales by Countries (2014-2019)

Table North America Dolutegravir Sales Market Share by Countries (2014-2019)

Figure North America Dolutegravir Sales Market Share by Countries (2014-2019)

Figure North America Dolutegravir Sales Market Share by Countries in 2018

Table North America Dolutegravir Revenue by Countries (2014-2019)

Table North America Dolutegravir Revenue Market Share by Countries (2014-2019)

Figure North America Dolutegravir Revenue Market Share by Countries (2014-2019)

Figure North America Dolutegravir Revenue Market Share by Countries in 2018

Figure United States Dolutegravir Sales and Growth Rate (2014-2019)

Figure Canada Dolutegravir Sales and Growth Rate (2014-2019)

Figure Mexico Dolutegravir Sales and Growth Rate (2014-2019)

Figure Europe Dolutegravir Revenue and Growth Rate (2014-2019)

Table Europe Dolutegravir Sales by Countries (2014-2019)

Table Europe Dolutegravir Sales Market Share by Countries (2014-2019)

Table Europe Dolutegravir Revenue by Countries (2014-2019)

Figure Europe Dolutegravir Revenue Market Share by Countries (2014-2019)

Figure Europe Dolutegravir Revenue Market Share by Countries in 2018

Figure Germany Dolutegravir Sales and Growth Rate (2014-2019)

Figure UK Dolutegravir Sales and Growth Rate (2014-2019)

Figure France Dolutegravir Sales and Growth Rate (2014-2019)

Figure Russia Dolutegravir Sales and Growth Rate (2014-2019)

Figure Italy Dolutegravir Sales and Growth Rate (2014-2019)

Figure Asia-Pacific Dolutegravir Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Dolutegravir Sales by Countries (2014-2019)

Table Asia-Pacific Dolutegravir Sales Market Share by Countries (2014-2019)

Figure Asia-Pacific Dolutegravir Sales Market Share by Countries 2018

Table Asia-Pacific Dolutegravir Revenue by Countries (2014-2019)

Figure Asia-Pacific Dolutegravir Revenue Market Share by Countries 2018

Figure China Dolutegravir Sales and Growth Rate (2014-2019)

Figure Japan Dolutegravir Sales and Growth Rate (2014-2019)

Figure Korea Dolutegravir Sales and Growth Rate (2014-2019)

Figure India Dolutegravir Sales and Growth Rate (2014-2019)

Figure Southeast Asia Dolutegravir Sales and Growth Rate (2014-2019)

Figure South America Dolutegravir Revenue and Growth Rate (2014-2019)

Table South America Dolutegravir Sales by Countries (2014-2019)

Table South America Dolutegravir Sales Market Share by Countries (2014-2019)

Figure South America Dolutegravir Sales Market Share by Countries in 2018

Table South America Dolutegravir Revenue by Countries (2014-2019)

Table South America Dolutegravir Revenue Market Share by Countries (2014-2019)

Figure South America Dolutegravir Revenue Market Share by Countries in 2018

Figure Brazil Dolutegravir Sales and Growth Rate (2014-2019)

Figure Argentina Dolutegravir Sales and Growth Rate (2014-2019)

Figure Colombia Dolutegravir Sales and Growth Rate (2014-2019)

Figure Middle East and Africa Dolutegravir Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Dolutegravir Sales by Countries (2014-2019)

Table Middle East and Africa Dolutegravir Sales Market Share by Countries (2014-2019)

Figure Middle East and Africa Dolutegravir Sales Market Share by Countries in 2018

Table Middle East and Africa Dolutegravir Revenue by Countries (2014-2019)

Table Middle East and Africa Dolutegravir Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Dolutegravir Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Dolutegravir Revenue Market Share by Countries in 2018

Figure Saudi Arabia Dolutegravir Sales and Growth Rate (2014-2019)

Figure UAE Dolutegravir Sales and Growth Rate (2014-2019)

Figure Egypt Dolutegravir Sales and Growth Rate (2014-2019)

Figure Nigeria Dolutegravir Sales and Growth Rate (2014-2019)

Figure South Africa Dolutegravir Sales and Growth Rate (2014-2019)

Table Global Dolutegravir Sales by Type (2014-2019)

Table Global Dolutegravir Sales Share by Type (2014-2019)

Table Global Dolutegravir Revenue by Type (2014-2019)

Table Global Dolutegravir Revenue Share by Type (2014-2019)

Figure Global 10mg Tablets Sales Growth (2014-2019)

Figure Global 10mg Tablets Price (2014-2019)

Figure Global 50mg Tablets Sales Growth (2014-2019)

Figure Global 50mg Tablets Price (2014-2019)

Table Global Dolutegravir Sales by Application (2014-2019)

Table Global Dolutegravir Sales Share by Application (2014-2019)

Figure Global Other Sales Growth (2014-2019)

Figure Global Dolutegravir Sales, Revenue and Growth Rate (2019-2024)

Table Global Dolutegravir Sales Forecast by Regions (2019-2024)

Table Global Dolutegravir Market Share Forecast by Regions (2019-2024)

Figure North America Sales Dolutegravir Market Forecast (2019-2024)

Figure Europe Sales Dolutegravir Market Forecast (2019-2024)

Figure Asia-Pacific Sales Dolutegravir Market Forecast (2019-2024)

Figure South America Sales Dolutegravir Market Forecast (2019-2024)

Figure Middle East and Africa Sales Dolutegravir Market Forecast (2019-2024)

Table Global Dolutegravir Sales Forecast by Type (2019-2024)

Table Global Dolutegravir Market Share Forecast by Type (2019-2024)

Table Global Dolutegravir Sales Forecast by Application (2019-2024)

Table Global Dolutegravir Market Share Forecast by Application (2019-2024)

Table Distributors/Traders/ Dealers List

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

ViiV Healthcare (GSK)

Shanghai Desano Pharmaceuticals

Mylan

Aurobindo Pharma

LAURUS Labs

Adcock Ingram Limited

Company Profile

Company Profile Title

Scope of the Report:

The worldwide market for Dolutegravir is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2024, from xx million USD in 2019, according to a new GIR (Global Info Research) study.

This report focuses on the Dolutegravir in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

ViiV Healthcare (GSK)

Shanghai Desano Pharmaceuticals

Mylan

Aurobindo Pharma

LAURUS Labs

Adcock Ingram Limited

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

10mg Tablets

50mg Tablets

Market Segment by Applications, can be divided into

Prevent HIV Infection Following Potential Exposure

Other

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Dolutegravir product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Dolutegravir, with price, sales, revenue and global market share of Dolutegravir in 2017 and 2018.

Chapter 3, the Dolutegravir competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Dolutegravir breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Dolutegravir market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Dolutegravir sales channel, distributors, customers, research findings and conclusion, appendix and data source.

READ MORE

Scope

Table of Contents

1 Market Overview

1.1 Dolutegravir Introduction

1.2 Market Analysis by Type

1.2.1 10mg Tablets

1.2.2 50mg Tablets

1.3 Market Analysis by Applications

1.3.1 Prevent HIV Infection Following Potential Exposure

1.3.2 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 ViiV Healthcare (GSK)

2.1.1 Business Overview

2.1.2 Dolutegravir Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 ViiV Healthcare (GSK) Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 Shanghai Desano Pharmaceuticals

2.2.1 Business Overview

2.2.2 Dolutegravir Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Shanghai Desano Pharmaceuticals Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 Mylan

2.3.1 Business Overview

2.3.2 Dolutegravir Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Mylan Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Aurobindo Pharma

2.4.1 Business Overview

2.4.2 Dolutegravir Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Aurobindo Pharma Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 LAURUS Labs

2.5.1 Business Overview

2.5.2 Dolutegravir Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 LAURUS Labs Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 Adcock Ingram Limited

2.6.1 Business Overview

2.6.2 Dolutegravir Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Adcock Ingram Limited Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Dolutegravir Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Dolutegravir Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Dolutegravir Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Dolutegravir Manufacturer Market Share in 2018

3.3.2 Top 6 Dolutegravir Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Dolutegravir Market Analysis by Regions

4.1 Global Dolutegravir Sales, Revenue and Market Share by Regions

4.1.1 Global Dolutegravir Sales and Market Share by Regions (2014-2019)

4.1.2 Global Dolutegravir Revenue and Market Share by Regions (2014-2019)

4.2 North America Dolutegravir Sales and Growth Rate (2014-2019)

4.3 Europe Dolutegravir Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Dolutegravir Sales and Growth Rate (2014-2019)

4.5 South America Dolutegravir Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Dolutegravir Sales and Growth Rate (2014-2019)

5 North America Dolutegravir by Country

5.1 North America Dolutegravir Sales, Revenue and Market Share by Country

5.1.1 North America Dolutegravir Sales and Market Share by Country (2014-2019)

5.1.2 North America Dolutegravir Revenue and Market Share by Country (2014-2019)

5.2 United States Dolutegravir Sales and Growth Rate (2014-2019)

5.3 Canada Dolutegravir Sales and Growth Rate (2014-2019)

5.4 Mexico Dolutegravir Sales and Growth Rate (2014-2019)

6 Europe Dolutegravir by Country

6.1 Europe Dolutegravir Sales, Revenue and Market Share by Country

6.1.1 Europe Dolutegravir Sales and Market Share by Country (2014-2019)

6.1.2 Europe Dolutegravir Revenue and Market Share by Country (2014-2019)

6.2 Germany Dolutegravir Sales and Growth Rate (2014-2019)

6.3 UK Dolutegravir Sales and Growth Rate (2014-2019)

6.4 France Dolutegravir Sales and Growth Rate (2014-2019)

6.5 Russia Dolutegravir Sales and Growth Rate (2014-2019)

6.6 Italy Dolutegravir Sales and Growth Rate (2014-2019)

7 Asia-Pacific Dolutegravir by Country

7.1 Asia-Pacific Dolutegravir Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Dolutegravir Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Dolutegravir Revenue and Market Share by Country (2014-2019)

7.2 China Dolutegravir Sales and Growth Rate (2014-2019)

7.3 Japan Dolutegravir Sales and Growth Rate (2014-2019)

7.4 Korea Dolutegravir Sales and Growth Rate (2014-2019)

7.5 India Dolutegravir Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Dolutegravir Sales and Growth Rate (2014-2019)

8 South America Dolutegravir by Country

8.1 South America Dolutegravir Sales, Revenue and Market Share by Country

8.1.1 South America Dolutegravir Sales and Market Share by Country (2014-2019)

8.1.2 South America Dolutegravir Revenue and Market Share by Country (2014-2019)

8.2 Brazil Dolutegravir Sales and Growth Rate (2014-2019)

8.3 Argentina Dolutegravir Sales and Growth Rate (2014-2019)

8.4 Colombia Dolutegravir Sales and Growth Rate (2014-2019)

9 Middle East and Africa Dolutegravir by Countries

9.1 Middle East and Africa Dolutegravir Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Dolutegravir Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Dolutegravir Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Dolutegravir Sales and Growth Rate (2014-2019)

9.3 Turkey Dolutegravir Sales and Growth Rate (2014-2019)

9.4 Egypt Dolutegravir Sales and Growth Rate (2014-2019)

9.5 Nigeria Dolutegravir Sales and Growth Rate (2014-2019)

9.6 South Africa Dolutegravir Sales and Growth Rate (2014-2019)

10 Global Dolutegravir Market Segment by Type

10.1 Global Dolutegravir Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Dolutegravir Sales and Market Share by Type (2014-2019)

10.1.2 Global Dolutegravir Revenue and Market Share by Type (2014-2019)

10.2 10mg Tablets Sales Growth and Price

10.2.1 Global 10mg Tablets Sales Growth (2014-2019)

10.2.2 Global 10mg Tablets Price (2014-2019)

10.3 50mg Tablets Sales Growth and Price

10.3.1 Global 50mg Tablets Sales Growth (2014-2019)

10.3.2 Global 50mg Tablets Price (2014-2019)

11 Global Dolutegravir Market Segment by Application

11.1 Global Dolutegravir Sales Market Share by Application (2014-2019)

11.2 Prevent HIV Infection Following Potential Exposure Sales Growth (2014-2019)

11.3 Other Sales Growth (2014-2019)

12 Dolutegravir Market Forecast (2019-2024)

12.1 Global Dolutegravir Sales, Revenue and Growth Rate (2019-2024)

12.2 Dolutegravir Market Forecast by Regions (2019-2024)

12.2.1 North America Dolutegravir Market Forecast (2019-2024)

12.2.2 Europe Dolutegravir Market Forecast (2019-2024)

12.2.3 Asia-Pacific Dolutegravir Market Forecast (2019-2024)

12.2.4 South America Dolutegravir Market Forecast (2019-2024)

12.2.5 Middle East and Africa Dolutegravir Market Forecast (2019-2024)

12.3 Dolutegravir Market Forecast by Type (2019-2024)

12.3.1 Global Dolutegravir Sales Forecast by Type (2019-2024)

12.3.2 Global Dolutegravir Market Share Forecast by Type (2019-2024)

12.4 Dolutegravir Market Forecast by Application (2019-2024)

12.4.1 Global Dolutegravir Sales Forecast by Application (2019-2024)

12.4.2 Global Dolutegravir Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Table

List of Tables and Figures

Figure Dolutegravir Picture

Table Product Specifications of Dolutegravir

Figure Global Sales Market Share of Dolutegravir by Types in 2018

Table Dolutegravir Types for Major Manufacturers

Figure 10mg Tablets Picture

Figure 50mg Tablets Picture

Figure Dolutegravir Sales Market Share by Applications in 2018

Figure Prevent HIV Infection Following Potential Exposure Picture

Figure Other Picture

Figure United States Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure Canada Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure Mexico Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure Germany Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure France Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure UK Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure Russia Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure Italy Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure China Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure Japan Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure Korea Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure India Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure Southeast Asia Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure Brazil Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure Egypt Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure Saudi Arabia Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure South Africa Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Figure Nigeria Dolutegravir Revenue (Value) and Growth Rate (2014-2024)

Table ViiV Healthcare (GSK) Basic Information, Manufacturing Base and Competitors

Table ViiV Healthcare (GSK) Dolutegravir Type and Applications

Table ViiV Healthcare (GSK) Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Shanghai Desano Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Shanghai Desano Pharmaceuticals Dolutegravir Type and Applications

Table Shanghai Desano Pharmaceuticals Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Mylan Basic Information, Manufacturing Base and Competitors

Table Mylan Dolutegravir Type and Applications

Table Mylan Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Aurobindo Pharma Basic Information, Manufacturing Base and Competitors

Table Aurobindo Pharma Dolutegravir Type and Applications

Table Aurobindo Pharma Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table LAURUS Labs Basic Information, Manufacturing Base and Competitors

Table LAURUS Labs Dolutegravir Type and Applications

Table LAURUS Labs Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Adcock Ingram Limited Basic Information, Manufacturing Base and Competitors

Table Adcock Ingram Limited Dolutegravir Type and Applications

Table Adcock Ingram Limited Dolutegravir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

Table Global Dolutegravir Sales by Manufacturer (2017-2018)

Figure Global Dolutegravir Sales Market Share by Manufacturer in 2017

Figure Global Dolutegravir Sales Market Share by Manufacturer in 2018

Table Global Dolutegravir Revenue by Manufacturer (2017-2018)

Figure Global Dolutegravir Revenue Market Share by Manufacturer in 2017

Figure Global Dolutegravir Revenue Market Share by Manufacturer in 2018

Figure Top 3 Dolutegravir Manufacturer (Revenue) Market Share in 2018

Figure Top 6 Dolutegravir Manufacturer (Revenue) Market Share in 2018

Figure Global Dolutegravir Sales and Growth Rate (2014-2019)

Figure Global Dolutegravir Revenue and Growth Rate (2014-2019)

Table Global Dolutegravir Sales by Regions (2014-2019)

Table Global Dolutegravir Sales Market Share by Regions (2014-2019)

Table Global Dolutegravir Revenue by Regions (2014-2019)

Figure Global Dolutegravir Revenue Market Share by Regions (2014-2019)

Figure Global Dolutegravir Revenue Market Share by Regions in 2018

Figure North America Dolutegravir Sales and Growth Rate (2014-2019)

Figure Europe Dolutegravir Sales and Growth Rate (2014-2019)

Figure Asia-Pacific Dolutegravir Sales and Growth Rate (2014-2019)

Figure South America Dolutegravir Sales and Growth Rate (2014-2019)

Figure Middle East and Africa Dolutegravir Sales and Growth Rate (2014-2019)

Figure North America Dolutegravir Revenue and Growth Rate (2014-2019)

Table North America Dolutegravir Sales by Countries (2014-2019)

Table North America Dolutegravir Sales Market Share by Countries (2014-2019)

Figure North America Dolutegravir Sales Market Share by Countries (2014-2019)

Figure North America Dolutegravir Sales Market Share by Countries in 2018

Table North America Dolutegravir Revenue by Countries (2014-2019)

Table North America Dolutegravir Revenue Market Share by Countries (2014-2019)

Figure North America Dolutegravir Revenue Market Share by Countries (2014-2019)

Figure North America Dolutegravir Revenue Market Share by Countries in 2018

Figure United States Dolutegravir Sales and Growth Rate (2014-2019)

Figure Canada Dolutegravir Sales and Growth Rate (2014-2019)

Figure Mexico Dolutegravir Sales and Growth Rate (2014-2019)

Figure Europe Dolutegravir Revenue and Growth Rate (2014-2019)

Table Europe Dolutegravir Sales by Countries (2014-2019)

Table Europe Dolutegravir Sales Market Share by Countries (2014-2019)

Table Europe Dolutegravir Revenue by Countries (2014-2019)

Figure Europe Dolutegravir Revenue Market Share by Countries (2014-2019)

Figure Europe Dolutegravir Revenue Market Share by Countries in 2018

Figure Germany Dolutegravir Sales and Growth Rate (2014-2019)

Figure UK Dolutegravir Sales and Growth Rate (2014-2019)

Figure France Dolutegravir Sales and Growth Rate (2014-2019)

Figure Russia Dolutegravir Sales and Growth Rate (2014-2019)

Figure Italy Dolutegravir Sales and Growth Rate (2014-2019)

Figure Asia-Pacific Dolutegravir Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Dolutegravir Sales by Countries (2014-2019)

Table Asia-Pacific Dolutegravir Sales Market Share by Countries (2014-2019)

Figure Asia-Pacific Dolutegravir Sales Market Share by Countries 2018

Table Asia-Pacific Dolutegravir Revenue by Countries (2014-2019)

Figure Asia-Pacific Dolutegravir Revenue Market Share by Countries 2018

Figure China Dolutegravir Sales and Growth Rate (2014-2019)

Figure Japan Dolutegravir Sales and Growth Rate (2014-2019)

Figure Korea Dolutegravir Sales and Growth Rate (2014-2019)

Figure India Dolutegravir Sales and Growth Rate (2014-2019)

Figure Southeast Asia Dolutegravir Sales and Growth Rate (2014-2019)

Figure South America Dolutegravir Revenue and Growth Rate (2014-2019)

Table South America Dolutegravir Sales by Countries (2014-2019)

Table South America Dolutegravir Sales Market Share by Countries (2014-2019)

Figure South America Dolutegravir Sales Market Share by Countries in 2018

Table South America Dolutegravir Revenue by Countries (2014-2019)

Table South America Dolutegravir Revenue Market Share by Countries (2014-2019)

Figure South America Dolutegravir Revenue Market Share by Countries in 2018

Figure Brazil Dolutegravir Sales and Growth Rate (2014-2019)

Figure Argentina Dolutegravir Sales and Growth Rate (2014-2019)

Figure Colombia Dolutegravir Sales and Growth Rate (2014-2019)

Figure Middle East and Africa Dolutegravir Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Dolutegravir Sales by Countries (2014-2019)

Table Middle East and Africa Dolutegravir Sales Market Share by Countries (2014-2019)

Figure Middle East and Africa Dolutegravir Sales Market Share by Countries in 2018

Table Middle East and Africa Dolutegravir Revenue by Countries (2014-2019)

Table Middle East and Africa Dolutegravir Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Dolutegravir Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Dolutegravir Revenue Market Share by Countries in 2018

Figure Saudi Arabia Dolutegravir Sales and Growth Rate (2014-2019)

Figure UAE Dolutegravir Sales and Growth Rate (2014-2019)

Figure Egypt Dolutegravir Sales and Growth Rate (2014-2019)

Figure Nigeria Dolutegravir Sales and Growth Rate (2014-2019)

Figure South Africa Dolutegravir Sales and Growth Rate (2014-2019)

Table Global Dolutegravir Sales by Type (2014-2019)

Table Global Dolutegravir Sales Share by Type (2014-2019)

Table Global Dolutegravir Revenue by Type (2014-2019)

Table Global Dolutegravir Revenue Share by Type (2014-2019)

Figure Global 10mg Tablets Sales Growth (2014-2019)

Figure Global 10mg Tablets Price (2014-2019)

Figure Global 50mg Tablets Sales Growth (2014-2019)

Figure Global 50mg Tablets Price (2014-2019)

Table Global Dolutegravir Sales by Application (2014-2019)

Table Global Dolutegravir Sales Share by Application (2014-2019)

Figure Global Other Sales Growth (2014-2019)

Figure Global Dolutegravir Sales, Revenue and Growth Rate (2019-2024)

Table Global Dolutegravir Sales Forecast by Regions (2019-2024)

Table Global Dolutegravir Market Share Forecast by Regions (2019-2024)

Figure North America Sales Dolutegravir Market Forecast (2019-2024)

Figure Europe Sales Dolutegravir Market Forecast (2019-2024)

Figure Asia-Pacific Sales Dolutegravir Market Forecast (2019-2024)

Figure South America Sales Dolutegravir Market Forecast (2019-2024)

Figure Middle East and Africa Sales Dolutegravir Market Forecast (2019-2024)

Table Global Dolutegravir Sales Forecast by Type (2019-2024)

Table Global Dolutegravir Market Share Forecast by Type (2019-2024)

Table Global Dolutegravir Sales Forecast by Application (2019-2024)

Table Global Dolutegravir Market Share Forecast by Application (2019-2024)

Table Distributors/Traders/ Dealers List

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

ViiV Healthcare (GSK)

Shanghai Desano Pharmaceuticals

Mylan

Aurobindo Pharma

LAURUS Labs

Adcock Ingram Limited